Wird geladen...
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
BACKGROUND: Persistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants wh...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2010
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045285/ https://ncbi.nlm.nih.gov/pubmed/20614421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000174.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|